The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer

Carolien Eggermont, Philippe Giron, Maxim Noeparast, Hugo Vandenplas, Pedro Aza-Blanc, Gustavo J Gutierrez, Jacques De Grève

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
50 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences